Novel Lung Cancer Therapy: Future Improvements and Challenges

ELCC 2023: novel lung cancer treatment strategiesПодробнее

Novel Therapies In Small Cell Lung Cancer (SCLC): LurbinectedinПодробнее

Novel Immunotherapy Combinations for NSCLCПодробнее

Molecularly Targeted Therapies in Oncology: Episode 3Подробнее

Key challenges in lung cancer treatmentПодробнее

Future challenges in lung cancer: long-term control and trial selectivityПодробнее

Novel immunotherapeutic strategies in lung cancerПодробнее

Novel therapy for Lung Cancer: From targeted therapy to immuno-therapy and back again!Подробнее

Novel Therapies for Advanced Small Cell Lung CancerПодробнее

Exploring novel therapeutics in lung cancer: insights from BTOG 2024Подробнее

The Design Behind the Development of a Novel-Risk Prediction Model in Lung Cancer ScreeningПодробнее

Novel KEAP1/NRF2 Target Gene Regulating Ferroptosis and Radioresistance in Lung Cancers | OncotargetПодробнее

The future of small cell lung cancer careПодробнее

Keynote - Novel Therapeutics in Cancer (Jose Baselga)Подробнее

Novel targeted therapies for NSCLC: Exploring HER2 dysregulationПодробнее

The successes of novel therapies and molecular testing in lung cancer and patient accessПодробнее

Lung Cancer: Novel CombinationsПодробнее

Novel Immunotherapy Combinations in NSCLCПодробнее

Overview of Novel Therapy for Advanced-Stage NSCLCПодробнее